102 On the flip side, many groups are advocating for the incorporation of novel markers, like a sophisticated karyotype55 or epigenetic subsets, 27,28 into clinical practice. Every one of these novel prognostic and/or predictive styles will have to be validated in cohorts of patients dealt with with specific agents.Klik tombol daftar di situs Net k